The FDA has given final approval to Mylan Pharmaceuticals Abbreviated New Drug Application (ANDA) for Acarbose Tablets, 25 mg, 50 mg and 100 mg. Acarbose is the generic version of Bayer’s Precose tablets, a treatment to be used with diet and exercise to improve glycemic control in adults with type 2 diabetes.
Acarbose tablets had U.S. sales of approximately $23 million for the 12 months ending Sept. 30, 2010, according to IMS Health. The product is available for immediate shipment.
Source: www.mylan.com
